메뉴 건너뛰기




Volumn 53, Issue 1, 2014, Pages 199-204

Therapeutic targeting of oncogenic K-ras by a covalent catalytic site inhibitor

(16)  Lim, Sang Min a,b,e   Westover, Kenneth D c   Ficarro, Scott B a   Harrison, Rane A d   Choi, Hwan Geun a,b   Pacold, Michael E a,f   Carrasco, Martin c   Hunter, John c   Kim, Nam Doo g   Xie, Ting a,b,e   Sim, Taebo h   Jänne, Pasi A a   Meyerson, Matthew a,b,i   Marto, Jarrod A a   Engen, John R d   Gray, Nathanael S a,b  


Author keywords

cancer; covalent inhibitors; drug design; K Ras

Indexed keywords

CANCER; CATALYTIC SITES; DRUG DESIGN; K-RAS; K-RAS INHIBITORS; PRODRUGS; THERAPEUTIC STRATEGY; WILD TYPES;

EID: 84890947640     PISSN: 14337851     EISSN: 15213773     Source Type: Journal    
DOI: 10.1002/anie.201307387     Document Type: Article
Times cited : (256)

References (30)
  • 6
    • 0024376173 scopus 로고
    • J. L. Bos, Cancer Res. 1989, 49, 4682-4689.
    • (1989) Cancer Res. , vol.49 , pp. 4682-4689
    • Bos, J.L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.